NatWest Group’s Medtronic MDT Stock Holding History

NatWest Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,867	Closed	-$610K	–	80
2020 Q3	$610K	Sell	5,867 -600	-9%	-$60.3K	0.13%	61
2020 Q2	$593K	Sell	6,467 -2,000	-24%	-$192K	0.16%	47
2020 Q1	$764K	Hold	8,467	–	–	0.21%	53
2019 Q4	$961K	Buy	+8,467	New	+$929K	0.21%	56
2015 Q4	–	Sell	-9,254	Closed	-$619K	–	255
2015 Q3	$619K	Sell	9,254 -326	-3%	-$24K	0.01%	256
2015 Q2	$710K	Buy	9,580 +1,967	+26%	+$150K	0.01%	218
2015 Q1	$594K	Buy	7,613 +227	+3%	+$17.2K	0.01%	298
2014 Q4	$533	Sell	7,386 -2,251	-23%	-$156K	﹤0.01%	303
2014 Q3	$597	Sell	9,637 -892	-8%	-$56.7K	0.01%	319
2014 Q2	$672K	Buy	10,529 +246	+2%	+$14.9K	0.03%	315
2014 Q1	$633K	Sell	10,283 -80,431	-89%	-$4.69M	0.03%	302
2013 Q4	$5.21M	Buy	90,714 +16,144	+22%	+$915K	0.13%	159
2013 Q3	$3.97M	Sell	74,570 -195,231	-72%	-$10.5M	0.12%	171
2013 Q2	$13.9M	Buy	+269,801	New	+$13.3M	0.2%	93

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NatWest Group's MDT Position: Q4 2020 in Review

NatWest Group sold out of Medtronic (MDT) in Q4 2020, closing a stake of 5,867 shares — an estimated $610K sold.

NatWest Group first reported a position in MDT in Q2 2013 and held it in 14 quarters. The position peaked at $13.9M in Q2 2013. 1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

NatWest Group reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
NatWest Group sold 5,867 Medtronic shares in Q4 2020, an estimated $610K.
NatWest Group first reported a position in Medtronic in Q2 2013 and held it in 14 quarters.
NatWest Group's Medtronic position peaked at $13.9M in Q2 2013.
1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on NatWest Group's 13F filing for Q4 2020, filed 4 Feb 2021.